Kidane Biniam, Jacob Nithin, Bruinooge Allan, Shen Yu Cindy, Keshavjee Shaf, dePerrot Marc E, Pierre Andrew F, Yasufuku Kazuhiro, Cypel Marcelo, Waddell Thomas K, Darling Gail E
Department of Surgery, Section of Thoracic Surgery, University of Manitoba, Winnipeg, MB, Canada.
Department of Surgery, Division of Thoracic Surgery, University of Toronto, Toronto General Hospital, Toronto, ON, Canada.
Eur J Cardiothorac Surg. 2020 Nov 1;58(5):1004-1009. doi: 10.1093/ejcts/ezaa107.
Transfusion of blood products has been associated with increased risk of post-pneumonectomy respiratory failure. It is unclear whether intraoperative or postoperative transfusions confer a higher risk of respiratory failure. Our objective was to assess the role of transfusions in developing post-pneumonectomy respiratory failure.
We performed a retrospective cohort study using prospectively collected data on consecutive pneumonectomies between 2005 and 2015. Patient records were reviewed for intraoperative/postoperative exposures. Univariable and multivariable analyses were performed.
Of the 251 pneumonectomies performed during the study period, 24 (9.6%) patients suffered respiratory failure. Ninety-day mortality was 5.6% (n = 14) and was more likely in patients with respiratory failure (7/24 vs 7/227, P < 0.001). Intraoperative and postoperative transfusions occurred in 42.2% (n = 106) and 44.6% (n = 112) of patients, respectively and were predominantly red blood cells. On univariable analysis, both intraoperative (P = 0.03) and postoperative transfusion (P = 0.004) were associated with a higher risk of respiratory failure. The multivariable model significantly predicted respiratory failure with an area under curve (AUC) = 0.88 (P = 0.001). On multivariable analysis, the only independent predictors of respiratory failure were postoperative transfusions [adjusted odds ratio (aOR) 6.54, 95% confidence interval (CI) 1.74-24.59; P = 0.005] and lower preoperative forced expiratory volume (adjusted OR 0.96, 95% CI 0.93-0.99; P = 0.03). Estimated blood loss was not significantly different (P = 0.91) between those with (median 800 ml, interquartile range 300-2000 ml) and without respiratory failure (median 800 ml, interquartile range 300-2000 ml).
Respiratory failure occurred in 9.6% of patients post-pneumonectomy and confers a higher risk of 90-day mortality. Postoperative (but not intraoperative) transfusion was the strongest independent predictor associated with respiratory failure. Intraoperative transfusion may be in reaction to active/unpredictable blood loss and may not be easily modifiable. However, postoperative transfusion may be modifiable and potentially avoidable. Transfusion thresholds should be assessed in light of potential cost-benefit trade-offs.
输注血液制品与肺切除术后呼吸衰竭风险增加相关。目前尚不清楚术中输血还是术后输血会带来更高的呼吸衰竭风险。我们的目的是评估输血在肺切除术后呼吸衰竭发生中的作用。
我们进行了一项回顾性队列研究,使用了2005年至2015年间前瞻性收集的连续肺切除术数据。对患者记录进行回顾以了解术中/术后输血情况。进行了单变量和多变量分析。
在研究期间进行的251例肺切除术中,24例(9.6%)患者发生呼吸衰竭。90天死亡率为5.6%(n = 14),呼吸衰竭患者的死亡率更高(7/24 vs 7/227,P < 0.001)。术中输血和术后输血分别发生在42.2%(n = 106)和44.6%(n = 112)的患者中,主要为红细胞输血。单变量分析显示,术中输血(P = 0.03)和术后输血(P = 0.004)均与呼吸衰竭风险较高相关。多变量模型对呼吸衰竭的预测具有显著意义,曲线下面积(AUC)= 0.88(P = 0.001)。多变量分析显示,呼吸衰竭的唯一独立预测因素是术后输血[调整后的优势比(aOR)6.54,95%置信区间(CI)1.74 - 24.59;P = 0.005]和术前较低的用力呼气量(调整后的OR 0.96,95% CI 0.93 - 0.99;P = 0.03)。有呼吸衰竭患者(中位数800 ml,四分位间距300 - 2000 ml)和无呼吸衰竭患者(中位数800 ml,四分位间距300 - 2000 ml)之间的估计失血量无显著差异(P = 0.91)。
9.6%的肺切除术后患者发生呼吸衰竭,并带来更高的90天死亡风险。术后(而非术中)输血是与呼吸衰竭相关的最强独立预测因素。术中输血可能是对活动性/不可预测失血的反应,可能不易改变。然而,术后输血可能是可改变的且潜在可避免的。应根据潜在的成本效益权衡来评估输血阈值。